Latest News for Glenveagh Properties Stock (OTC:GLVHF)

Glenveagh Properties PLC is engaged in homebuilding in Ireland. The company is organized into three key reportable segments, The Suburban segment is engaged in housing (with some low-rise apartments) with demand from private buyers and institutions. The urban segment is engaged in developing apartments to deliver to institutional investors. The apartments are located in Dublin and Cork and on sites adjacent to rail transportation hubs. The partnerships segment involves the Government, local authorities, or state agencies contributing their land on a reduced cost or phased basis into a development agreement with Glenveagh. Its product is delivered back to the government or local authority via social and affordable homes.

GLENVEAGH PROPERTIES PLC by Glenveagh Properties Plc

Glenveagh Properties PLC

Wedbush analyst Seth Basham maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Neutral and raises the price target from $235 to $270.

News

Price Target

Analyst Ratings

TSCO

Wedbush Maintains Neutral on Tractor Supply, Raises Price Target to $270

Barclays analyst Brandt Montour maintains Wyndham Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WH#NYSE">WH</a>) with a Overweight and raises the price target from $87 to $88.

Barclays Maintains Overweight on Wyndham Hotels & Resorts, Raises Price Target to $88

Piper Sandler analyst Stephen Scouten reiterates Origin Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBK#NYSE">OBK</a>) with a Neutral and raises the price target from $30 to $32.

Reiteration

Piper Sandler Reiterates Neutral on Origin Bancorp, Raises Price Target to $32

Wedbush analyst Jay McCanless reiterates Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) with a Underperform and maintains $148 price target.

Wedbush Reiterates Underperform on Meritage Homes, Maintains $148 Price Target

Barclays analyst David Anderson maintains Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) with a Overweight and raises the price target from $135 to $160.

WFRD

Barclays Maintains Overweight on Weatherford International, Raises Price Target to $160

Piper Sandler analyst Alex Twerdahl reiterates Amalgamated Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAL#NASDAQ">AMAL</a>) with a Overweight and raises the price target from $28 to $29.

AMAL

Piper Sandler Reiterates Overweight on Amalgamated Financial, Raises Price Target to $29

Wedbush analyst Tom Nikic maintains Skechers USA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) with a Outperform and raises the price target from $68 to $76.

Wedbush Maintains Outperform on Skechers USA, Raises Price Target to $76

Piper Sandler analyst Alexander Potter maintains Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) with a Neutral and raises the price target from $31 to $32.

MBLY

Piper Sandler Maintains Neutral on Mobileye Global, Raises Price Target to $32

Barclays analyst Andrew Mok maintains Universal Health Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) with a Equal-Weight and raises the price target from $181 to $189.

Barclays Maintains Equal-Weight on Universal Health Servs, Raises Price Target to $189

Wedbush analyst David Nierengarten reiterates Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) with a Outperform and maintains $110 price target.

BPMC

Wedbush Reiterates Outperform on Blueprint Medicines, Maintains $110 Price Target

Piper Sandler analyst Clarke Jeffries maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and raises the price target from $520 to $529.

Piper Sandler Maintains Overweight on Tyler Technologies, Raises Price Target to $529

WIIM

Edwards Lifesciences shares are trading lower after the company reported Q1 financial results and issued guidance.

Since 2021, Dogecoin (DOGE) has consistently been one of the largest cryptocurrencies in the market. The token has attracted tens of billions in investment and is up more than 27,000% since its launch.&nbsp;
While the price has fallen considerably since highs, the token has held its own and performed well in 2024. Some do not see the growth stopping anytime soon. According to some analysts, DOGE could reach — and even surpass — the $100 mark.
Don't Miss:
<ul>
<li>Dogecoin millionaires are increasing —<a href="https://www.benzinga.com/money/dogecoin-millionaires-adv"> investors with $1M+ in DOGE revealed!</a></li>
<li>Bitcoin has jumped another 45% already this year &#8211;<a href="https://www.benzinga.com/money/kraken"> how much would you need to get started today?</a></li>
</ul>
The analysis, posted on <a href="https://www.tradingview.com/chart/DOGEUSD/DiRXML0c-Dogecoin-just-getting-started/">TradingView</a>, is titled "Dogecoin is just getting started" and shows complex charting patterns that could lead to a $100 DOGE. Specifically, the chart uses the Bitcoin halvings as a marker for the beginning of a repeating trend in which DOGE runs up in price after the halving, reaches new highs around 12 to 18 months after and then falls exponentially before gapping up at the start of the next halving to create new highs.&nbsp;
Based on this pattern and applying it to the current cycle and price level, the analysis shows that the target price is $27 for the next all-time high (ATH). The pattern then shows that DOGE could reach $27 by October, before falling as low as $2.60 in 2025.&nbsp;
The next halving is expected to occur in the first half of 2028. This could mark another period of price increases in which DOGE could reach new highs of over $100.&nbsp;
Trending: If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.
According to the analysis, however, this cycle could be different.
"Possibly more volatility. Markets are moving faster and the four-year cycle might get shorter and shorter as the gains come faster then long bear markets ensue again. Possible top this October 2024 for dogecoin and later for other alts," the TradingView analyst stated.
The analyst also believes that other events would have to occur for DOGE to reach $100.
"If hyperbitcoinization happens due to dollar index breaking down and starting a decade-long downward trend then DOGE will go even higher than $27, possibly to $100 and beyond."
The prediction of a $100 DOGE relies on "hyperbitcoinization," a scenario in which Bitcoin surpasses traditional money. While that is unlikely to happen by 2028, it could happen well into the future. With this in mind, a $100 DOGE is a possibility, though perhaps not on the timeline indicated by the analyst.
However, it is still interesting to think about what a $100 DOGE would look like. At that price, 10,000 DOGE would be worth $1 million. Currently, 10,000 DOGE is worth around $1,500. This means that a $100 DOGE would result in a price increase of over 66,000%. While this is not unheard of in the crypto space, it would also result in a market cap of over $14 trillion — roughly 25 times the size of JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>). While it is unlikely that this will happen, it is not impossible. 
Read Next:
<ul>
<li>About 22% of the adult population in the U.S. own a share of Bitcoin,<a href="https://www.benzinga.com/money/kraken"> how much would $10 get you today</a>?</li>
<li>The<a href="https://www.benzinga.com/money/kraken-2"> last-standing top crypto exchange without a major security breach</a> offers what now?</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Holding 10,000 Dogecoin Could Make You A Millionaire, Predicts Crypto Analyst

Phillips 66&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>)&nbsp;shares are trading lower after it reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38455690/phillips-66-reports-1q-2024-financial-results-highlights-strategic-priorities-progress" rel="noreferrer noopener">first-quarter FY24 results</a>.
Revenue of $36.436 billion exceeded the consensus of $33.075 billion.&nbsp;Adjusted EPS of $1.90 missed&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">the consensus of $2.17</a>.
Midstream segment adjusted pre-tax income stood at $613 million, vs. $754 million in the fourth quarter of fiscal 2023.
The Chemicals segment adjusted pre-tax income&nbsp;stood at&nbsp;$205 million vs. $106 million in the prior quarter. Global olefins and polyolefins utilization was at 96% for the quarter.
The Refining segment adjusted pre-tax income&nbsp;stood&nbsp;at $228 million (vs. $797 million prior quarter)&nbsp;and&nbsp;Marketing&nbsp;and Specialties segment adjusted pre-tax income declined to $345 million from $432 million&nbsp;prior&nbsp;quarter.
Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38452288/phillips-66-gears-up-for-q1-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-c" rel="noreferrer noopener">Phillips 66 Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
Phillips 66's operating cash flow stood at $1.2 billion in the quarter, excluding working capital impacts of $1.4 billion, mainly due to inventory builds.&nbsp;
As of March-end, the company had cash and cash equivalents of $1.6 billion&nbsp;and committed capacity available under its credit facility worth $3.5 billion.&nbsp;
During the quarter, Phillips 66 funded $1.2 billion&nbsp;in&nbsp;share repurchases, $448 million in dividends, and&nbsp;$628 million&nbsp;in&nbsp;capital expenditures and investments.
Phillips 66 continued to project shareholder distributions of $13 billion to&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/01/36870959/petroleum-refineries-major-phillips-66-shares-are-up-today-details" rel="noreferrer noopener">$15 billion by 2024.</a>
Phillips 66 achieved $1.2 billion in run-rate cost and capital reductions as of March 31, with a&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$1.4 billion target for 2024</a>.
Investors can gain exposure to the stock via&nbsp;IShares U.S. Oil &amp; Gas Exploration &amp; Production ETF&nbsp;(BATS:<a class="ticker" href="https://www.benzinga.com/stock/IEO#BATS">IEO</a>) and&nbsp;VanEck Oil Refiners ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRAK#NYSE">CRAK</a>).
Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37953212/phillips-66-explores-sale-of-rockies-express-pipeline-stake-worth-over-1b-report" rel="noreferrer noopener">Phillips 66 Explores Sale Of Rockies Express Pipeline Stake Worth Over $1B:&nbsp;Report</a>
Price Action: PSX shares are down 3.7% at $151.40 at the last check Friday.
Photo via Shutterstock

Earnings

Equities

Large Cap

Guidance

Movers

CRAK

iShares Dow Jones US Oil & Gas Exploration & Production Index Fund

Why Petroleum Refineries Major Phillips 66 Shares Are Falling Today

Barclays analyst Jeremy Campbell maintains Tradeweb Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) with a Overweight and raises the price target from $118 to $122.

Barclays Maintains Overweight on Tradeweb Markets, Raises Price Target to $122

Piper Sandler analyst Paul Newsome maintains Willis Towers Watson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTW#NASDAQ">WTW</a>) with a Overweight and raises the price target from $297 to $303.

Piper Sandler Maintains Overweight on Willis Towers Watson, Raises Price Target to $303

Piper Sandler analyst Rob Owens maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Neutral and lowers the price target from $225 to $200.

TEAM

Piper Sandler Maintains Neutral on Atlassian, Lowers Price Target to $200

Barclays analyst Seth Sigman maintains Tractor Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>) with a Equal-Weight and raises the price target from $234 to $240.

Barclays Maintains Equal-Weight on Tractor Supply, Raises Price Target to $240

Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) has outperformed the market over the past 15 years by 4.15% on an annualized basis producing an average annual return of 16.33%. Currently, Steel Dynamics has a market capitalization of $21.01 billion. 
Buying $100 In STLD: If an investor had bought $100 of STLD stock 15 years ago, it would be worth $1,039.48 today based on a price of $133.03 for STLD at the time of writing.
<h3>Steel Dynamics's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714141819_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

STLD

$100 Invested In Steel Dynamics 15 Years Ago Would Be Worth This Much Today

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) has outperformed the market over the past 10 years by 8.67% on an annualized basis producing an average annual return of 19.12%. Currently, Novo Nordisk has a market capitalization of $565.70 billion. 
Buying $1000 In NVO: If an investor had bought $1000 of NVO stock 10 years ago, it would be worth $5,586.46 today based on a price of $126.80 for NVO at the time of writing.
<h3>Novo Nordisk's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714141814_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.